176 related articles for article (PubMed ID: 17206305)
1. Elevated cerebrospinal fluid beta-2 microglobulin as a tumor marker in a patient with myeloma of the central nervous system.
Alsobhi EM; Hashim IA; Abdelaal MA; Aljifri AM; Alshamy AM
Saudi Med J; 2007 Jan; 28(1):128-30. PubMed ID: 17206305
[TBL] [Abstract][Full Text] [Related]
2. Elevated cerebrospinal fluid b-2 microglobulin as a tumor marker in a patient with myeloma of the central nervous system.
Alsobhi EM; Hashim IA; Abdelaal MA; Aljifri AM; Alshamy AM
Neurosciences (Riyadh); 2007 Jan; 12(1):68-70. PubMed ID: 21857623
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid beta-2-microglobulin level as marker of central nervous system involvement in lymphoma.
Pagano L; Marra R; Storti S; De Stefano V; Bizzi B
Haematologia (Budap); 1986; 19(2):121-5. PubMed ID: 3530906
[TBL] [Abstract][Full Text] [Related]
4. Distribution of beta2-microglobulin in cerebrospinal fluid and in cystic fluid of brain tumors. A preliminary study.
Schaub C; Bluet-Pajot MT; Szikla G; Lornet-Videau C; Mounier F; Talairach J
Pathol Biol (Paris); 1978 Sep; 26(6):381-5. PubMed ID: 83592
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic and prognostic significance of some laboratory indices of cerebrospinal fluid in multiple myeloma].
Bessmel'tsev SS; Lubo-Lesnichenko IF; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV; Gubarenko NK
Vopr Onkol; 2000; 46(5):574-7. PubMed ID: 11202190
[TBL] [Abstract][Full Text] [Related]
6. [Beta 2-microglobulin and tumors of the central nervous system].
Hrazdirová V; Hrazdira CL; Polcáková M
Cesk Neurol Neurochir; 1990 Jan; 53(1):17-21. PubMed ID: 2185897
[TBL] [Abstract][Full Text] [Related]
7. The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system.
Chang H; Bartlett ES; Patterson B; Chen CI; Yi QL
Br J Haematol; 2005 May; 129(4):539-41. PubMed ID: 15877737
[TBL] [Abstract][Full Text] [Related]
8. [beta2-Microglobulin determination's estimation in cerebrospinal fluid (author's transl)].
Lavocat C; Merienne L; Ziegler M; Fauchier P; Riche F; Askienazy S
Pathol Biol (Paris); 1978 Sep; 26(6):387-9. PubMed ID: 83593
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma of the central nervous system: a clinicopathological review.
Al-Sobhi E; Osoba AO; Karar A; Zuraiki AM
East Mediterr Health J; 2009; 15(6):1570-9. PubMed ID: 20218151
[TBL] [Abstract][Full Text] [Related]
10. [CSF levels and diagnostic utility of cerebrospinal fluid beta2-microglobulin].
Caudie C; Bancel J; Dupont M; Matanza D; Poitevin F; Honnorat J
Ann Biol Clin (Paris); 2005; 63(6):631-7. PubMed ID: 16330382
[TBL] [Abstract][Full Text] [Related]
11. [Beta 2 microglobulin in some hematologic neoplasms].
Rodríguez MA; Lira P; Foradori A; Grebe G
Rev Med Chil; 1989 Jun; 116(6):538-42. PubMed ID: 2664940
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement.
Lazzarin A; Castagna A; Cavalli G; Amprimo MC; Vaj M; Parravicini CL; Costanzi G; Ronchi P; Foppa CU; Moroni M; Turconi R
J Clin Lab Immunol; 1992; 38(4):175-86. PubMed ID: 11270518
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination.
Mavlight GM; Stuckey SE; Cabanillas FF; Keating MJ; Tourtellotte WW; Schold SC; Freireich EJ
N Engl J Med; 1980 Sep; 303(13):718-22. PubMed ID: 6157089
[TBL] [Abstract][Full Text] [Related]
14. Serum beta 2-microglobulin as a tumour marker in space occupying lesions of central nervous system.
Kumar S; Mathur MD; Anand R; Mehndiratta MM; Anand R
Indian J Pathol Microbiol; 1995 Jan; 38(1):43-7. PubMed ID: 8919468
[TBL] [Abstract][Full Text] [Related]
15. [A case of adenoid cystic carcinoma manifesting Garcin's syndrome--effectiveness of cerebrospinal fluid ferritin as a tumor marker in malignant CNS involvement].
Sanjo N; Komiya T; Tamaki M; Arai M; Fukaya S
Rinsho Shinkeigaku; 1994 Aug; 34(8):838-41. PubMed ID: 7994994
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
[TBL] [Abstract][Full Text] [Related]
17. Meningeal and cerebral involvement in multiple myeloma patients.
Patriarca F; Zaja F; Silvestri F; Sperotto A; Scalise A; Gigli G; Fanin R
Ann Hematol; 2001 Dec; 80(12):758-62. PubMed ID: 11797120
[TBL] [Abstract][Full Text] [Related]
18. Beta-2-microglobulin concentration in cerebrospinal fluid--monitoring of malignant lymphoma in the central nervous system.
Imagawa S; Aoki Y; Ninomiya H; Yoda Y; Abe T
Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1059-64. PubMed ID: 3904291
[No Abstract] [Full Text] [Related]
19. [Abnormal cerebrospinal fluid plasma cells in a case of myeloma].
Sato Y; Mizoguchi K; Ohta Y
No To Shinkei; 1986 Apr; 38(4):399-403. PubMed ID: 3718784
[TBL] [Abstract][Full Text] [Related]
20. [Initial central nervous system involvement in a case of non-secretory multiple myeloma].
Calavia J; Loyola I; Richard C; Baro J; Recio M; Cuadrado MA; Zubizarreta A
Sangre (Barc); 1993 Oct; 38(5):389-91. PubMed ID: 8140502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
